Feng et al. demonstrated that miR-31a-5p targets TP53 to promote primary hypertension through accelerating proliferation and inhibiting apoptosis of arterial smooth muscle cells, suggesting a potential role of TP53 in pulmonary arterial hypertension [39]. This evidence concerns the gene TP53 and essential hypertension.